Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00026546 · ClinicalTrials.gov registry record

Behavior in Children With Attention Deficit Hyperactivity Disorder and in Healthy Volunteers

A clinical trial, sponsored by National Institute of Mental Health (NIMH).

Completed
Registry status
189
Enrollment target

NCT00026546: Completed study, sponsored by National Institute of Mental Health (NIMH).

NCT00026546 is a clinical trial that has completed, run by National Institute of Mental Health (NIMH). The registered enrollment target is 189 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00026546 has completed, sponsored by National Institute of Mental Health (NIMH).

COMPLETED
Registry status
189 participants
Enrollment target

Study Summary

The purpose of this study is to determine how the brain controls motor activity in children with attention deficit hyperactivity disorder (ADHD). The inability to control one s behavior is an important symptom of many psychiatric illnesses. The stop signal paradigm which involves withholding a motor response to a go signal, has proved useful in assessing uncontrolled behavior in children with ADHD and other disorders. This study will use a stop signal paradigm in order to evaluate the ability of children with and without ADHD to control their motor behavior. A magnetic resonance imaging (MRI) scan will be used to study how the brain works during specific activities. This study will evaluate the stop signal paradigm in three groups of people: healthy children, children with ADHD, and healthy adults. This study comprises two sub-studies: a behavioral study in which participants perform simple activities and an MRI study. Participants will be asked to stop any over-the-counter medication 5 days before entering the behavioral or MRI study. Children with ADHD will be asked to stop taking medication for ADHD 72 hours before the study. All participants will have a medical history and a psychiatric evaluation (for children, both parents and children provide information for the assessment). Participants in the MRI study will also have physical examinations and blood and urine tests. All children will undergo intelligence tests; and those with ADHD will have tests to confirm the diagnosis. The parents of child participants will complete an autism screening questionnaire.

Trial Details

FieldValue
Enrollment Target 189 participants
Start Date 2001-11-07
Est. Completion 2018-10-09

What the finished NCT00026546 record still lists

NCT00026546 is an observational study that tracks outcomes without assigning an intervention. The registered 189 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 0 interventions.

NCT00026546 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00026546 about?

NCT00026546 is a clinical study titled "Behavior in Children With Attention Deficit Hyperactivity Disorder and in Healthy Volunteers". The purpose of this study is to determine how the brain controls motor activity in children with attention deficit hyperactivity disorder (ADHD). The inability to control one s behavior is an important symptom of many psychiatric illnesses. The stop signal paradigm which involves withholding a moto...

What is the current status of trial NCT00026546?

This trial is currently completed. The enrollment target is 189 participants. The study started on 2001-11-07. Estimated completion is 2018-10-09.

Who is sponsoring clinical trial NCT00026546?

This trial is sponsored by National Institute of Mental Health (NIMH), which has 343 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02734537 · 189 participants · Phase 2

    Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

  • NCT05058651 · 189 participants · Phase 2

    Evaluating the Addition of the Immunotherapy Drug Atezolizumab to Standard Chemotherapy Treatment for Advanced or Metastatic Neuroendocrine Carcinomas That Originate Outside the Lung

  • NCT05673408 · 189 participants

    NIBP Validation Study

  • NCT05994209 · 189 participants · Phase 1

    Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT00026546, the US trial registry maintained by the National Library of Medicine. NCT00026546 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.